APGE
Price
$88.43
Change
+$3.19 (+3.74%)
Updated
Jun 17 closing price
Capitalization
6.67B
60 days until earnings call
Intraday BUY SELL Signals
NBTX
Price
$35.95
Change
-$0.12 (-0.33%)
Updated
Jun 18, 10:37 AM (EDT)
Capitalization
1.78B
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APGE vs NBTX

APGE vs NBTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
APGE vs. NBTX commentary
Jun 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and NBTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 18, 2026
Stock price -- (APGE: $88.43 vs. NBTX: $35.90)
Brand notoriety: APGE and NBTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 145% vs. NBTX: 93%
Market capitalization -- APGE: $6.67B vs. NBTX: $1.78B
APGE [@Biotechnology] is valued at $6.67B. NBTX’s [@Biotechnology] market capitalization is $1.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $116.49B to $0. The average market capitalization across the [@Biotechnology] industry is $1.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileNBTX’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • NBTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both APGE and NBTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 5 TA indicator(s) are bullish while NBTX’s TA Score has 2 bullish TA indicator(s).

  • APGE’s TA Score: 5 bullish, 4 bearish.
  • NBTX’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, APGE is a better buy in the short-term than NBTX.

Price Growth

APGE (@Biotechnology) experienced а +6.90% price change this week, while NBTX (@Biotechnology) price change was +7.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.07%. For the same industry, the average monthly price growth was +6.59%, and the average quarterly price growth was +2219.87%.

Reported Earning Dates

APGE is expected to report earnings on Aug 17, 2026.

NBTX is expected to report earnings on Sep 30, 2026.

Industries' Descriptions

@Biotechnology (+4.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($6.67B) has a higher market cap than NBTX($1.78B). NBTX YTD gains are higher at: 55.277 vs. APGE (17.157).
APGENBTXAPGE / NBTX
Capitalization6.67B1.78B374%
EBITDA-303.65MN/A-
Gain YTD17.15755.27731%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash1.06BN/A-
Total Debt8.05MN/A-
TECHNICAL ANALYSIS
Technical Analysis
APGENBTX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 15 days ago
86%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 1 day ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signal:
Gain/Loss:
NBTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
MLN.X1.5095550.038094
+2.59%
Enzyme cryptocurrency
APT.X0.6703570.001694
+0.25%
Aptos cryptocurrency
LSK.X0.092913-0.001418
-1.50%
Lisk cryptocurrency
HOT.X0.000315-0.000005
-1.51%
Holo cryptocurrency
AGIX.X0.087268-0.003375
-3.72%
SingularityNET cryptocurrency

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+3.74%
SYRE - APGE
48%
Loosely correlated
+4.89%
ORKA - APGE
42%
Loosely correlated
+4.68%
AVBP - APGE
42%
Loosely correlated
+3.40%
CLDX - APGE
40%
Loosely correlated
+1.89%
XNCR - APGE
40%
Loosely correlated
+4.75%
More